Regeneron Pharmaceuticals Inc’s COVID-19 antibody treatment and other similar drugs could be less effective against the new Omicron coronavirus variant, the company said on Tuesday. The drugmaker said further analyses are ongoing to confirm and quantify this potential impact using the actual Omicron variant sequence. Global markets fell on Tuesday […]